---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-246494"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2022-09-16T23:59:59+00:00"
generated_at: "2026-06-23T09:12:34.809646+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# FLAG shareholders approve extension to Dec 14; 18.9M shares redeemed, co-CEO appointed

## Summary
- Stockholders approved extension of business combination deadline to Dec 14, 2022, with three additional 3-month extensions possible.
- Redemption of 18,871,976 shares, leaving 4,128,024 shares outstanding; trust account now $41.6M.
- Issued extension notes totaling $490,000 to sponsor and Metric to fund extension and working capital.
- Appointed Thomas A. Vecchiolla as co-CEO alongside William J. Weber, effective Sept 15, 2022.

## SEC filing metadata
- accession: 0001193125-22-246494
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2022-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.03, 2.03, 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000119312522246494/0001193125-22-246494-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000119312522246494/d361604d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-246494
- JSON: https://secwatch.observer/filing/0001193125-22-246494.json
- Plain text: https://secwatch.observer/filing/0001193125-22-246494.txt

## Key facts
- Executive change
  Thomas A. Vecchiolla was appointed as co-Chief Executive Officer at Calidi Biotherapeutics, Inc..
  - Action: appointed
  - Role: co-Chief Executive Officer
  source text: Effective September 15, 2022, the Company’s board of directors appointed Thomas A. Vecchiolla as co-Chief Executive Officer to serve in such role with William J. Weber, who will also serve as co-Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855485/000119312522246494/0001193125-22-246494-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.